Amir Hossein Doustimotlagh
Overview
Explore the profile of Amir Hossein Doustimotlagh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirghaed A, Mansourian M, Abdzadeh S, Azizi M, Karimi F, Behrouj H, et al.
Curr Pharm Des
. 2025 Feb;
PMID: 39945248
Introduction: Eprosartan is an effective blood pressure medication that blocks the Angiotensin Type 1 (AT1) receptor. The studies conducted on Eprosartan showed anti-oxidative stress effects and modulating inflammatory mechanisms. The...
2.
Mohammadi S, Saniee N, Mousaviasl S, Radmanesh E, Doustimotlagh A
Iran J Public Health
. 2024 Dec;
53(11):2432-2439.
PMID: 39619893
Background: Osteoporosis is the most common systemic skeletal disease worldwide. We aimed to review the latest studies related to osteocalcin and osteoporosis to clarify this relationship more precisely. Methods: A...
3.
Koushki M, Doustimotlagh A, Amiri-Dashatan N, Farahani M, Chiti H, Vanda R, et al.
J Diabetes Metab Disord
. 2024 Nov;
23(2):2173-2182.
PMID: 39610499
Purpose: A growing number of evidence have assessed the association between bisphenol A (BPA) as an endocrine-disrupting agent and the risk of gestational diabetes (GDM). This meta-analysis aimed to reassess...
4.
Shakerinasab N, Mottaghipisheh J, Eftekhari M, Sadeghi H, Bazarganipour F, Abbasi R, et al.
J Ethnopharmacol
. 2024 Oct;
337(Pt 1):118969.
PMID: 39455345
No abstract available.
5.
Akbari G, Abasi M, Gharaghani M, Nouripoor S, Shakerinasab N, Azizi M, et al.
Res Pharm Sci
. 2024 Jul;
19(2):217-227.
PMID: 39035584
Background And Purpose: Cholestasis is caused by a malfunction of the biliary liver system. Oxidative stress plays an essential role in the progression of cholestasis. This study aimed to investigate...
6.
Mottaghipisheh J, Kamali M, Doustimotlagh A, Nowroozzadeh M, Rasekh F, Hashempur M, et al.
Front Pharmacol
. 2024 Apr;
15:1322083.
PMID: 38576489
Plants, renowned for their rich reservoir of metabolites, play a pivotal role in addressing health-related issues. The Verbenaceae family stands out, showcasing immense potential in preventing and treating chronic diseases....
7.
Hassanzadeh S, Azarmehr N, Jahanshahi A, Malekzadeh J, Doustimotlagh A
Saudi J Kidney Dis Transpl
. 2023 Sep;
33(Supplement):S241-S247.
PMID: 37675751
Acute and chronic kidney diseases are common and are associated with the risk of kidney failure. Early detection of these disorders prevents their progression to kidney damage in later stages....
8.
Rajizadeh M, Bejeshk M, Doustimotlagh A, Najafipour H, Eftekhari M, Mahmoodi M, et al.
Iran J Allergy Asthma Immunol
. 2023 Jul;
22(2):138-149.
PMID: 37496407
Asthma is an inflammatory disease of the airways. We assessed the anti-inflammatory and antioxidative impacts of quercetin, a plant derivative, on inflammatory and oxidative indices in lung tissue and serum...
9.
Barmoudeh Z, Fouani M, Moslemi Z, Azizi M, Doustimotlagh A, Bardania H
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Jul;
397(1):395-410.
PMID: 37452836
In the current study, the therapeutic effectiveness of the metformin (Met) and melatonin (Mel) co-loaded liposomes was investigated on cholestasis induced by bile duct ligation (BDL) in male rats. Histopathological...
10.
Shakerinasab N, Mottaghipisheh J, Eftekhari M, Sadeghi H, Bazarganipour F, Abbasi R, et al.
J Ethnopharmacol
. 2023 Jul;
318(Pt A):116862.
PMID: 37437789
Ethnopharmacological Relevance: Asthma is a common chronic disease characterized by inflammation of the airways. One of the most devastating consequences of this inflammatory process is the production of reactive oxygen...